|
⚲
|
| Keyboard |
| Maimon Yossi
✚
|
|
|---|---|
| CIK # | 0001385115 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001385115] | |
| 4 | [0001385115] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Maimon Yossi | |
| Old Ayala Inc | |
| Protalix BioTherapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Old Ayala Inc AYLA
Common Stock
|
2023-01-19 | Disposed to issuer | 69,872 | ||
|
Old Ayala Inc AYLA
Stock Option (right to buy) · derivative
|
2023-01-19 | Disposed to issuer | 31,950 | ||
|
Old Ayala Inc AYLA
Stock Option (right to buy) · derivative
|
2023-01-19 | Disposed to issuer | 19,170 | ||
|
Old Ayala Inc AYLA
Stock Option (right to buy) · derivative
|
2023-01-19 | Disposed to issuer | 9,460 | ||
|
Old Ayala Inc AYLA
Stock Option (right to buy) · derivative
|
2023-01-19 | Disposed to issuer | 70,500 | ||
|
Old Ayala Inc AYLA
Common Stock
|
2022-05-16 | Grant | 50,000 | $0.00 | |
|
Old Ayala Inc AYLA
Stock Option · derivative
|
2022-01-03 | Grant | 31,950 | $0.00 | |
|
Old Ayala Inc AYLA
Common Stock
|
2021-01-04 | Grant | 8,520 | $0.00 | |
|
Old Ayala Inc AYLA
Stock Option · derivative
|
2021-01-04 | Grant | 19,170 | $0.00 | |
|
Old Ayala Inc AYLA
Common Stock
|
2020-05-07 | Grant | 11,352 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2018-09-13 | Grant | 700,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2015-12-14 | Buy | 10,000 | $0.78 | 7,800 |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2015-03-23 | Grant | 250,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-07-16 | Grant | 185,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Sell | 125,964 | $7.13 | 898,123 |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Option exercise | 50,000 | $2.65 | 132,500 |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2012-05-02 | Option exercise | 50,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2012-05-02 | Option exercise | 75,964 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Option exercise | 75,964 | $0.97 | 73,685 |